Patent Assignment
Reel/Frame 068866/0697
Assignment of Assignor's Interest
Recorded: 2024-10-10
Pages: 4
Assignor
LE, HENRY TRONG
Executed: 2011-10-18
Assignee
KERYX BIOPHARMACEUTICALS, INC.
245 FIRST STREET, SUITE 1400, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(3)
Ferric Citrate Dosage Forms
Application:
18/124,079 →
Ferric Citrate Dosage Forms
Application:
18/501,536 →
Ferric Citrate Dosage Forms
Application:
18/743,646 →
Publication:
US 2025/0144064
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Fifteenth Amended and Restated Intellectual Property Security Agreement
Jan 4, 2024
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 066205/0143 →
Security Interest
Jan 29, 2024
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: KREOS CAPITAL VII (UK) LIMITED
Reel/Frame 066377/0654 →
Termination and Release of Security Interest in Patents
Jun 25, 2024
From: BIOPHARMA CREDIT PLC
To: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 067839/0134 →
First Supplement to Patent Security Agreement
Apr 9, 2025
From: KERYX BIOPHARMACEUTICALS, INC.
To: KREOS CAPITAL VII (UK) LIMITED
Reel/Frame 070786/0163 →